Pill touted to help women with low libido fails expert scrutiny. June 19, 2010— -- An expert U.S. Food and Drug Administration panel at a hearing Friday did not recommended approval for a German ...

This Friday, the U.S. Food and Drug Administration will hear from an expert panel about the merits of, flibanserin, a drug that has been touted as potentially being the female equivalent of Viagra.

The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...

Flibanserine, commonly called the “female Viagra,” aims to boost sexual desire in women, and has already been rejected twice by the FDA due to side effects of fainting, nausea, dizziness, sleepiness ...

The drug aptly dubbed “female Viagra,” which will reportedly help women ramp up their sexual drive, may have inched its way closer to the marketplace. An advisory committee voted Thursday to recommend ...

WASHINGTON/NEW YORK (Reuters) - The first drug to treat low sexual desire in women won approval from U.S. health regulators on Tuesday, but with a warning about potentially dangerous low blood ...

Chicago - Viagra's effect in women has been disappointing, but a new small study finds those on antidepressants may benefit from taking the little blue pills. The research involving 98 premenopausal ...

NASHVILLE, Tenn. (WKRN) – For years there has been a pill out there to help men with their sex drive. But now a pill for women is one step closer to being available. “It’s a really difficult thing to ...

CHICAGO — Viagra's effect in women has been disappointing, but a new small study finds those on anti- depressants may benefit from taking the little blue pills. The research, involving 98 ...